Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Lisa Bero

Concepts (697)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Conflict of Interest
81
2023
119
22.050
Why?
Drug Industry
61
2023
103
15.480
Why?
Research Support as Topic
39
2021
107
9.090
Why?
Tobacco Industry
34
2018
46
7.790
Why?
Industry
27
2024
64
6.220
Why?
Publication Bias
24
2020
36
6.020
Why?
Publishing
34
2022
123
5.910
Why?
Research Design
32
2023
916
5.680
Why?
Disclosure
29
2022
100
5.660
Why?
Review Literature as Topic
23
2022
61
5.310
Why?
Health Policy
24
2022
330
5.040
Why?
Biomedical Research
25
2022
581
4.960
Why?
Public Health
28
2023
433
4.770
Why?
Evidence-Based Medicine
26
2023
662
4.630
Why?
World Health Organization
23
2022
101
4.580
Why?
Policy Making
20
2022
80
4.280
Why?
Practice Guidelines as Topic
22
2021
1378
3.970
Why?
Meta-Analysis as Topic
17
2022
155
3.620
Why?
Randomized Controlled Trials as Topic
24
2024
1205
3.390
Why?
Bias
19
2024
178
3.310
Why?
Scientific Misconduct
5
2022
11
3.120
Why?
Pharmaceutical Preparations
10
2022
163
3.050
Why?
Mobile Applications
8
2020
140
3.010
Why?
Australia
25
2023
205
2.880
Why?
Editorial Policies
10
2021
44
2.670
Why?
Nutritional Sciences
6
2019
37
2.620
Why?
Smoking
25
2016
1380
2.600
Why?
Periodicals as Topic
18
2020
180
2.460
Why?
Humans
257
2024
113531
2.440
Why?
Environmental Exposure
6
2021
370
2.440
Why?
Smoking Prevention
12
2012
156
2.370
Why?
Health Personnel
10
2021
569
2.350
Why?
Food Industry
6
2020
14
2.230
Why?
Clinical Trials as Topic
18
2021
922
2.160
Why?
Nutrition Policy
5
2020
54
2.150
Why?
Observational Studies as Topic
6
2024
89
2.120
Why?
Equipment and Supplies
8
2020
37
2.030
Why?
Research Report
5
2019
75
2.030
Why?
Environmental Health
7
2019
30
1.990
Why?
Information Dissemination
10
2021
185
1.950
Why?
Guideline Adherence
8
2019
489
1.880
Why?
United States Food and Drug Administration
14
2015
172
1.860
Why?
Marketing
9
2021
24
1.830
Why?
Tobacco Smoke Pollution
16
2006
218
1.730
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2018
371
1.730
Why?
Ethics, Research
5
2020
32
1.650
Why?
Environmental Pollutants
6
2018
110
1.630
Why?
Government Regulation
12
2019
46
1.560
Why?
Drugs, Essential
5
2018
6
1.540
Why?
Propaganda
3
2019
3
1.530
Why?
Public Policy
7
2016
61
1.520
Why?
Research
18
2020
387
1.510
Why?
Politics
8
2020
79
1.400
Why?
United States
65
2023
12137
1.400
Why?
Peer Review, Research
9
2015
34
1.370
Why?
Data Collection
9
2019
616
1.370
Why?
Qualitative Research
13
2023
924
1.360
Why?
Cross-Sectional Studies
28
2023
4400
1.330
Why?
Physicians
12
2023
765
1.290
Why?
Evidence-Based Practice
4
2020
185
1.280
Why?
Authorship
10
2020
30
1.280
Why?
Nutritional Status
5
2020
286
1.260
Why?
Coronavirus Infections
4
2021
325
1.250
Why?
Guidelines as Topic
7
2020
241
1.250
Why?
Delivery of Health Care
5
2024
828
1.230
Why?
Bibliometrics
5
2018
43
1.180
Why?
Pharmacy and Therapeutics Committee
2
2020
2
1.150
Why?
Commerce
8
2020
61
1.140
Why?
Vitamin D
2
2021
339
1.130
Why?
Policy
4
2022
137
1.110
Why?
Community Pharmacy Services
2
2022
42
1.100
Why?
Interprofessional Relations
5
2021
246
1.090
Why?
Research Personnel
4
2017
147
1.080
Why?
Cardiovascular Diseases
7
2021
1725
1.080
Why?
Risk Management
2
2022
89
1.060
Why?
Health Promotion
8
2019
675
1.060
Why?
Occupational Health
5
2019
165
1.040
Why?
Drug Approval
5
2015
78
1.040
Why?
Education, Medical, Continuing
4
2019
115
1.040
Why?
Bone and Bones
2
2021
275
1.010
Why?
Deprescriptions
5
2023
27
0.980
Why?
Practice Patterns, Physicians'
12
2021
1176
0.970
Why?
Lobbying
6
2006
8
0.960
Why?
Diet
5
2020
1076
0.960
Why?
Interrupted Time Series Analysis
7
2022
46
0.950
Why?
Risk Assessment
10
2022
2953
0.930
Why?
Toxicity Tests
3
2016
28
0.900
Why?
Financial Support
5
2019
18
0.900
Why?
Medical Overuse
4
2019
30
0.900
Why?
Spinal Cord Stimulation
1
2024
7
0.890
Why?
Workplace
4
2009
221
0.890
Why?
Telemedicine
4
2019
666
0.870
Why?
Pandemics
7
2023
1308
0.870
Why?
Advanced Practice Nursing
1
2023
19
0.870
Why?
Consumer Advocacy
2
2020
12
0.860
Why?
Formularies as Topic
3
2018
6
0.850
Why?
Codeine
1
2022
7
0.840
Why?
Dietary Supplements
2
2021
459
0.820
Why?
Health Education
2
2018
316
0.810
Why?
Decision Making
9
2014
761
0.800
Why?
Health Priorities
2
2012
34
0.790
Why?
Nursing Care
1
2022
30
0.790
Why?
Epidemiologic Methods
2
2022
71
0.790
Why?
Drug Evaluation
5
2012
77
0.790
Why?
Confidentiality
2
2021
67
0.770
Why?
Tobacco Products
4
2018
96
0.770
Why?
Retraction of Publication as Topic
1
2021
1
0.750
Why?
Recommended Dietary Allowances
1
2021
18
0.750
Why?
Interviews as Topic
7
2019
574
0.740
Why?
Attitude
4
2013
227
0.740
Why?
Group Practice
1
2021
7
0.730
Why?
Advisory Committees
6
2020
206
0.730
Why?
Bone Remodeling
1
2021
65
0.720
Why?
Atherosclerosis
2
2015
342
0.720
Why?
Technology Transfer
2
2019
12
0.710
Why?
Calcium
2
2021
1086
0.710
Why?
Contact Tracing
1
2020
14
0.710
Why?
Gift Giving
2
2019
9
0.700
Why?
Betacoronavirus
2
2020
246
0.700
Why?
Checklist
1
2021
85
0.690
Why?
Science
3
2007
45
0.690
Why?
Societies, Scientific
1
2020
46
0.680
Why?
Societies
1
2020
36
0.680
Why?
Organizational Policy
7
2011
67
0.680
Why?
Beverages
2
2019
60
0.680
Why?
Attitude to Health
6
2015
398
0.670
Why?
Databases, Factual
5
2020
1127
0.670
Why?
Marketing of Health Services
3
2018
12
0.660
Why?
Dental Research
1
2019
8
0.660
Why?
Calcium, Dietary
1
2019
54
0.650
Why?
Patient Advocacy
2
2019
65
0.650
Why?
Whole Grains
1
2019
3
0.650
Why?
Off-Label Use
3
2015
51
0.650
Why?
Pharmacists
7
2022
231
0.640
Why?
Analgesics, Opioid
7
2023
770
0.640
Why?
Selection Bias
2
2017
33
0.640
Why?
Gynecology
1
2021
163
0.630
Why?
Tobacco Use Disorder
4
2010
230
0.630
Why?
Hazardous Substances
2
2018
9
0.630
Why?
Internet
4
2019
590
0.630
Why?
Developing Countries
4
2018
231
0.620
Why?
Public Opinion
6
2015
59
0.620
Why?
International Cooperation
7
2011
168
0.620
Why?
Journalism
2
2012
5
0.620
Why?
Professional Role
4
2022
148
0.610
Why?
Cooperative Behavior
3
2013
376
0.610
Why?
Vitamins
1
2019
150
0.610
Why?
Nicotine
8
2006
263
0.610
Why?
Health Behavior
4
2021
701
0.610
Why?
Fluorocarbons
2
2023
94
0.610
Why?
Pneumonia, Viral
2
2020
333
0.610
Why?
Quality Control
8
2013
142
0.600
Why?
Food Analysis
1
2018
18
0.600
Why?
Writing
2
2019
81
0.600
Why?
Access to Information
3
2014
46
0.590
Why?
Pharmaceutical Services
3
2013
76
0.590
Why?
Health Services
3
2013
103
0.590
Why?
Capital Financing
1
2017
5
0.580
Why?
Databases, Bibliographic
3
2014
29
0.580
Why?
Disease Outbreaks
1
2020
305
0.580
Why?
Nurses
2
2016
145
0.570
Why?
Population Health
1
2018
42
0.570
Why?
Cannabis
1
2023
382
0.560
Why?
Vaccines
1
2022
372
0.560
Why?
Opioid-Related Disorders
2
2023
412
0.560
Why?
Interinstitutional Relations
5
2013
54
0.550
Why?
Peer Review
5
2015
42
0.550
Why?
Drug Evaluation, Preclinical
2
2015
158
0.540
Why?
Government Agencies
2
2015
15
0.540
Why?
Primary Prevention
1
2018
171
0.540
Why?
Tobacco Use Cessation
1
2016
20
0.530
Why?
Sweetening Agents
1
2016
37
0.530
Why?
Drug Prescriptions
4
2022
237
0.520
Why?
California
9
2013
351
0.520
Why?
Atrazine
1
2015
8
0.510
Why?
Drug Overdose
1
2020
292
0.510
Why?
Libraries, Digital
2
2012
4
0.510
Why?
Medicaid
4
2013
404
0.500
Why?
Cohort Studies
7
2022
4880
0.500
Why?
Pharmacies
1
2015
32
0.500
Why?
Fetal Development
2
2016
248
0.490
Why?
Patient Care Planning
1
2016
138
0.490
Why?
Databases, Pharmaceutical
1
2015
5
0.490
Why?
Obesity
3
2017
2501
0.490
Why?
Anticoagulants
1
2019
548
0.490
Why?
Epidemiologic Studies
2
2022
57
0.480
Why?
Models, Organizational
2
2008
140
0.480
Why?
Academic Medical Centers
4
2018
406
0.480
Why?
Fees, Pharmaceutical
2
2014
13
0.480
Why?
Air Pollution, Indoor
2
2009
100
0.480
Why?
Medication Adherence
1
2019
530
0.480
Why?
Information Services
4
2002
42
0.480
Why?
Canada
7
2022
320
0.470
Why?
Treatment Outcome
15
2018
9006
0.470
Why?
Quality of Health Care
4
2012
572
0.470
Why?
Knowledge
2
2012
48
0.470
Why?
Caprylates
1
2014
19
0.470
Why?
Occupational Exposure
3
2022
254
0.460
Why?
Expert Testimony
3
2020
36
0.460
Why?
Teaching Materials
2
2007
23
0.450
Why?
Universities
4
2007
337
0.450
Why?
Depressive Disorder, Major
1
2017
300
0.440
Why?
Social Support
1
2017
534
0.440
Why?
Counseling
1
2016
342
0.440
Why?
Substance-Related Disorders
7
2016
931
0.440
Why?
Community Participation
2
2010
112
0.430
Why?
Ambulatory Care
3
2010
480
0.430
Why?
Mass Media
5
2001
37
0.430
Why?
Cyclohexanecarboxylic Acids
3
2009
22
0.420
Why?
Amines
3
2009
34
0.420
Why?
Financial Management
3
2012
15
0.420
Why?
Cholesterol, LDL
1
2014
306
0.410
Why?
Angiogenesis Inhibitors
1
2014
212
0.410
Why?
Overweight
1
2016
473
0.410
Why?
Attitude of Health Personnel
7
2023
970
0.410
Why?
Macular Degeneration
1
2014
152
0.410
Why?
Carcinogens
2
2020
101
0.410
Why?
Thinking
1
2013
49
0.400
Why?
Health Services Accessibility
4
2015
756
0.400
Why?
gamma-Aminobutyric Acid
3
2009
141
0.400
Why?
Body Weight
1
2016
853
0.400
Why?
Global Health
3
2020
287
0.390
Why?
Medication Therapy Management
1
2013
67
0.390
Why?
Device Approval
4
2015
21
0.390
Why?
Federal Government
3
2009
26
0.380
Why?
Birth Weight
1
2014
440
0.380
Why?
Human Experimentation
2
2009
12
0.380
Why?
Publications
3
2020
38
0.370
Why?
Thrombosis
1
2014
293
0.370
Why?
Oncologists
2
2021
30
0.370
Why?
Health Knowledge, Attitudes, Practice
6
2021
1168
0.370
Why?
Decision Support Techniques
1
2014
336
0.370
Why?
Patient Education as Topic
2
2013
665
0.370
Why?
Prejudice
3
2017
54
0.360
Why?
Organizations, Nonprofit
1
2011
17
0.360
Why?
Teaching
1
2013
197
0.360
Why?
Decision Making, Organizational
2
2007
22
0.360
Why?
Relief Work
1
2010
20
0.350
Why?
Child Welfare
1
2012
190
0.340
Why?
Public Relations
5
2017
6
0.340
Why?
Antibodies, Monoclonal, Humanized
1
2014
654
0.340
Why?
Women's Health
1
2012
270
0.340
Why?
Congresses as Topic
4
1997
194
0.340
Why?
Cluster Analysis
1
2011
448
0.340
Why?
Drug Labeling
2
2013
42
0.340
Why?
Drug-Related Side Effects and Adverse Reactions
5
2014
239
0.330
Why?
Health Care Sector
2
2020
24
0.330
Why?
Prescription Drugs
4
2017
116
0.330
Why?
Occupational Diseases
2
2022
128
0.320
Why?
Health Care Costs
4
2019
381
0.320
Why?
Poverty
2
2010
437
0.320
Why?
Economic Development
1
2009
3
0.320
Why?
Ethics, Institutional
1
2009
4
0.320
Why?
Social Control Policies
1
2008
1
0.320
Why?
Life Style
2
2021
427
0.320
Why?
Ethics, Professional
1
2009
14
0.320
Why?
Neoplasms
8
2023
2082
0.310
Why?
Restaurants
1
2008
16
0.310
Why?
Law Enforcement
1
2008
36
0.310
Why?
Thiazolidinediones
1
2009
134
0.300
Why?
Morals
1
2009
65
0.300
Why?
Laboratories
1
2009
95
0.300
Why?
Trust
2
2019
103
0.290
Why?
Uncertainty
2
2021
90
0.290
Why?
Ethics Committees, Research
1
2007
38
0.290
Why?
Privacy
3
2020
28
0.280
Why?
Research Subjects
1
2007
40
0.280
Why?
Minority Groups
1
2009
225
0.280
Why?
Drug and Narcotic Control
3
2021
29
0.280
Why?
Smoking Cessation
5
2018
373
0.280
Why?
Consumer Organizations
1
2007
1
0.280
Why?
Osteoporosis
3
2021
224
0.280
Why?
Plants, Toxic
6
1995
22
0.280
Why?
Nutritional Physiological Phenomena
2
2017
47
0.280
Why?
Deception
1
2007
16
0.280
Why?
Europe
4
2021
331
0.280
Why?
Health Status Disparities
1
2009
200
0.270
Why?
Books
1
2006
3
0.270
Why?
Aerospace Medicine
1
2006
17
0.270
Why?
Aircraft
1
2006
26
0.260
Why?
United States Dept. of Health and Human Services
1
2006
2
0.260
Why?
Adolescent Behavior
2
2002
481
0.260
Why?
Nonprescription Drugs
1
2006
68
0.250
Why?
Disease
2
2019
85
0.250
Why?
Consumer Product Safety
3
2019
30
0.250
Why?
Animals
19
2020
31162
0.250
Why?
Insurance Claim Reporting
1
2005
21
0.250
Why?
MEDLINE
3
2014
22
0.250
Why?
Documentation
4
2018
166
0.250
Why?
Female
23
2023
59115
0.240
Why?
Bone Density
1
2009
432
0.240
Why?
Drug Utilization
3
2022
164
0.240
Why?
Data Interpretation, Statistical
3
2017
315
0.240
Why?
Harm Reduction
1
2004
24
0.230
Why?
Case-Control Studies
2
2024
2993
0.230
Why?
International Classification of Diseases
1
2005
115
0.230
Why?
Antihypertensive Agents
1
2007
427
0.230
Why?
Cost-Benefit Analysis
4
2015
542
0.220
Why?
Evaluation Studies as Topic
3
2019
165
0.220
Why?
Male
19
2023
55112
0.220
Why?
Data Accuracy
2
2021
48
0.220
Why?
Receptors, Opioid
3
1988
19
0.220
Why?
Consultants
2
2020
12
0.220
Why?
Quarantine
2
2020
24
0.220
Why?
Schizophrenia
1
2007
409
0.220
Why?
Data Mining
2
2015
100
0.220
Why?
Sample Size
2
2014
107
0.210
Why?
Mental Health
2
2019
559
0.210
Why?
Journal Impact Factor
3
2020
27
0.210
Why?
Prolactin
4
1987
93
0.210
Why?
Drug Therapy
5
2011
74
0.210
Why?
State Government
3
2009
41
0.210
Why?
Estonia
2
2012
2
0.210
Why?
Private Sector
2
2000
51
0.210
Why?
Alcohol Drinking
1
2008
651
0.210
Why?
Health Status
2
2021
716
0.210
Why?
Datasets as Topic
2
2020
98
0.210
Why?
Program Development
2
2016
338
0.200
Why?
Risk
2
2016
807
0.200
Why?
Risk Factors
7
2022
8606
0.200
Why?
Fraud
1
2022
8
0.200
Why?
Child
9
2020
18340
0.200
Why?
Analgesics
1
2023
156
0.200
Why?
Artificial Intelligence
1
2023
144
0.200
Why?
Libraries, Medical
1
2002
8
0.200
Why?
Torsades de Pointes
1
2022
17
0.200
Why?
Newspapers as Topic
2
2001
9
0.190
Why?
Truth Disclosure
7
2011
39
0.190
Why?
Program Evaluation
4
2020
821
0.190
Why?
History, 21st Century
2
2018
158
0.190
Why?
Chemical Industry
2
2013
9
0.190
Why?
Double-Blind Method
2
2018
1643
0.190
Why?
Healthcare Disparities
2
2021
479
0.190
Why?
Medical Oncology
1
2023
229
0.180
Why?
Long QT Syndrome
1
2022
59
0.180
Why?
Adult
9
2023
30245
0.180
Why?
Facility Regulation and Control
1
2000
2
0.180
Why?
Sodium, Dietary
1
2021
36
0.180
Why?
Infant Formula
1
2021
74
0.180
Why?
Faculty, Medical
2
2000
226
0.180
Why?
Health Care Surveys
2
2013
541
0.180
Why?
Administrative Personnel
1
2020
29
0.180
Why?
Sierra Leone
1
2020
2
0.180
Why?
Botswana
1
2020
7
0.180
Why?
Patient Isolation
1
2020
14
0.180
Why?
United States Agency for Healthcare Research and Quality
1
2020
9
0.180
Why?
Thiadiazines
1
2020
2
0.170
Why?
Whooping Cough
1
2020
48
0.170
Why?
Codes of Ethics
2
2018
16
0.170
Why?
Medicare
1
2005
661
0.170
Why?
Hemorrhagic Fever, Ebola
1
2020
33
0.170
Why?
Organizational Case Studies
3
2010
68
0.170
Why?
Reproduction
1
2021
174
0.170
Why?
Psychology, Adolescent
1
2000
61
0.170
Why?
Chronic Pain
1
2023
207
0.170
Why?
Food Safety
1
2020
18
0.170
Why?
Postpartum Hemorrhage
1
2019
13
0.170
Why?
Dabigatran
1
2019
22
0.170
Why?
Retrospective Studies
5
2022
12504
0.160
Why?
Models, Theoretical
2
2020
505
0.160
Why?
Nutritive Value
1
2019
30
0.160
Why?
Social Control, Formal
1
2019
11
0.160
Why?
Food Supply
1
2020
63
0.160
Why?
Antineoplastic Agents
1
2009
1872
0.160
Why?
Organizational Affiliation
2
2000
8
0.160
Why?
Computer Security
1
2019
18
0.160
Why?
Secondary Prevention
1
2020
220
0.160
Why?
Stakeholder Participation
1
2019
72
0.160
Why?
Schools
1
2002
393
0.160
Why?
Middle Aged
5
2023
26552
0.150
Why?
Pyridones
1
2019
122
0.150
Why?
Health Risk Behaviors
1
2018
13
0.150
Why?
Intersectoral Collaboration
1
2018
55
0.150
Why?
Information Storage and Retrieval
2
2015
106
0.150
Why?
Morphine
4
1987
121
0.150
Why?
Patient Satisfaction
2
2017
570
0.150
Why?
Eating
1
2020
340
0.150
Why?
Professional Practice
1
1998
63
0.150
Why?
Practice Management, Medical
1
2018
34
0.150
Why?
Oral Health
1
2020
140
0.150
Why?
Food
1
2019
159
0.150
Why?
Statistics as Topic
1
2019
287
0.150
Why?
United Kingdom
3
2022
224
0.150
Why?
Urinary Bladder, Overactive
1
2018
20
0.150
Why?
Costs and Cost Analysis
2
2022
195
0.150
Why?
Rivaroxaban
1
2019
211
0.140
Why?
Tuberculosis
1
2020
239
0.140
Why?
Leadership
1
2020
291
0.140
Why?
Pregnancy
6
2019
5490
0.140
Why?
Environmental Monitoring
1
2018
250
0.140
Why?
Health Resources
1
2018
119
0.140
Why?
Linear Models
2
2020
767
0.140
Why?
Patient Participation
2
1997
348
0.140
Why?
Food Handling
1
2016
49
0.140
Why?
Patient Selection
2
2011
625
0.130
Why?
Nutrition Assessment
1
2016
75
0.130
Why?
Triclosan
1
2016
9
0.130
Why?
Pyrazoles
1
2019
361
0.130
Why?
Statistics, Nonparametric
2
2012
384
0.130
Why?
Primary Health Care
2
2020
1502
0.130
Why?
Brain Chemistry
2
1988
112
0.130
Why?
Venous Thromboembolism
1
2019
231
0.130
Why?
Judgment
1
2016
55
0.130
Why?
Endocrine Disruptors
1
2016
34
0.130
Why?
Information Centers
1
1995
4
0.130
Why?
Thyroxine
1
2016
57
0.130
Why?
Epidemiologic Research Design
1
2016
27
0.130
Why?
Malnutrition
1
2016
62
0.130
Why?
Infant, Newborn
2
2020
5032
0.130
Why?
5-Hydroxytryptophan
2
1987
19
0.130
Why?
Sex Factors
2
2012
1705
0.130
Why?
Surveys and Questionnaires
6
2022
4593
0.130
Why?
Calcium Channel Blockers
1
1996
112
0.120
Why?
Hypertension
2
2010
1051
0.120
Why?
Depression
1
2003
1131
0.120
Why?
Health
1
2015
73
0.120
Why?
Depressive Disorder
1
2018
330
0.120
Why?
Ranibizumab
1
2014
18
0.120
Why?
Medical Informatics
1
2015
90
0.120
Why?
Italy
1
2014
92
0.120
Why?
Nursing Staff, Hospital
1
2016
123
0.110
Why?
Adverse Drug Reaction Reporting Systems
2
2011
68
0.110
Why?
Vaccination
1
2022
1198
0.110
Why?
Bevacizumab
1
2014
113
0.110
Why?
Lung Neoplasms
2
2005
2148
0.110
Why?
Legislation, Food
1
2013
2
0.110
Why?
Food Additives
1
2013
7
0.110
Why?
History, 20th Century
2
2007
265
0.110
Why?
Equipment Safety
2
2010
40
0.110
Why?
Combined Modality Therapy
1
2016
1114
0.110
Why?
Nursing Homes
1
2015
138
0.110
Why?
Physician's Role
1
2015
192
0.110
Why?
Search Engine
1
2013
9
0.110
Why?
Health Services Research
1
1996
373
0.110
Why?
Clinical Protocols
2
2009
231
0.100
Why?
Antipsychotic Agents
1
2015
183
0.100
Why?
Health Planning Guidelines
1
2012
24
0.100
Why?
Wounds and Injuries
1
2019
674
0.100
Why?
Reimbursement Mechanisms
1
2013
76
0.100
Why?
Random Allocation
1
2013
326
0.100
Why?
Total Quality Management
1
2012
61
0.100
Why?
Gastroenterology
1
2014
159
0.100
Why?
Diabetes Mellitus
1
2020
896
0.100
Why?
Pain
3
2023
699
0.100
Why?
Legislation, Drug
2
2010
78
0.100
Why?
Switzerland
1
2011
20
0.090
Why?
Comprehension
1
2013
146
0.090
Why?
Americas
1
2011
17
0.090
Why?
Mammography
1
2012
101
0.090
Why?
Guatemala
1
2012
267
0.090
Why?
Libraries
1
2011
3
0.090
Why?
Prevalence
3
2022
2244
0.090
Why?
Cardiac Resynchronization Therapy Devices
1
2011
10
0.090
Why?
Health Services Needs and Demand
1
2013
241
0.090
Why?
Eclampsia
1
2010
4
0.090
Why?
Self Concept
1
2012
214
0.090
Why?
Time Factors
1
2021
6032
0.090
Why?
Tocolytic Agents
1
2010
15
0.090
Why?
Serotonin
3
1987
284
0.090
Why?
Magnesium Sulfate
1
2010
16
0.090
Why?
Age Factors
2
2012
2875
0.090
Why?
Educational Status
1
2012
404
0.090
Why?
Quality Assurance, Health Care
3
2012
309
0.090
Why?
Mental Disorders
1
2018
884
0.090
Why?
Multicenter Studies as Topic
1
2011
248
0.090
Why?
Education, Pharmacy, Continuing
1
2010
3
0.090
Why?
Health Surveys
1
2012
440
0.090
Why?
Informed Consent
1
2011
158
0.090
Why?
Health Facilities
1
2010
71
0.090
Why?
Dose-Response Relationship, Drug
2
2014
1822
0.090
Why?
Rats, Inbred Strains
5
1988
355
0.090
Why?
Radiology
1
2012
137
0.080
Why?
Reproducibility of Results
5
2016
2752
0.080
Why?
Mandatory Programs
1
2009
14
0.080
Why?
Prostheses and Implants
1
2010
134
0.080
Why?
Heart-Assist Devices
1
2015
493
0.080
Why?
Disasters
1
2010
86
0.080
Why?
Growth Hormone
2
1987
95
0.080
Why?
Vinyl Chloride
1
2009
2
0.080
Why?
Rats
8
2016
4829
0.080
Why?
Multivariate Analysis
2
2006
1421
0.080
Why?
Learning
1
2012
344
0.080
Why?
Lead Poisoning
1
2009
17
0.080
Why?
Financing, Government
1
2009
40
0.080
Why?
Placebos
1
2009
198
0.080
Why?
Pre-Eclampsia
1
2010
165
0.080
Why?
Silicosis
1
2009
22
0.080
Why?
Methadone
2
1987
77
0.080
Why?
Socioeconomic Factors
1
2012
1080
0.080
Why?
Smartphone
2
2019
73
0.080
Why?
Motivation
2
2020
486
0.080
Why?
Adolescent
4
2010
17724
0.070
Why?
Coronary Disease
1
2010
347
0.070
Why?
Helsinki Declaration
1
2007
2
0.070
Why?
Aged
5
2014
18944
0.070
Why?
Longitudinal Studies
2
2022
2361
0.070
Why?
Logistic Models
2
2006
1832
0.070
Why?
Health Plan Implementation
1
2008
132
0.070
Why?
Reference Values
1
2009
735
0.070
Why?
Financing, Organized
3
2003
33
0.070
Why?
Receptors, Dopamine
1
1987
12
0.070
Why?
Propylamines
1
1987
11
0.070
Why?
Cardiology
1
2009
260
0.070
Why?
Persuasive Communication
1
2007
12
0.070
Why?
Consumer Behavior
2
2004
65
0.070
Why?
Receptors, Serotonin
1
1987
31
0.070
Why?
Fluoxetine
1
1987
46
0.070
Why?
Culture
1
2007
122
0.070
Why?
Regression Analysis
1
2009
932
0.070
Why?
Mothers
1
2012
651
0.070
Why?
Prospective Studies
5
2020
6189
0.070
Why?
Patient Readmission
1
1991
608
0.070
Why?
Receptors, Adrenergic, alpha
1
1986
28
0.070
Why?
Hypothalamus
1
1987
139
0.070
Why?
United States Public Health Service
1
2006
8
0.060
Why?
Ethics, Medical
2
1999
69
0.060
Why?
Catecholamines
1
1986
92
0.060
Why?
Geography
1
2006
173
0.060
Why?
United States Government Agencies
1
2005
6
0.060
Why?
Mass Screening
1
2012
978
0.060
Why?
Forms and Records Control
1
2005
21
0.060
Why?
Health Maintenance Organizations
2
2003
94
0.060
Why?
Economic Competition
1
2004
13
0.060
Why?
Alkaloids
1
2004
20
0.060
Why?
Academies and Institutes
1
2005
44
0.060
Why?
Electronic Health Records
1
2011
801
0.060
Why?
Anticonvulsants
1
2006
176
0.060
Why?
Emergency Service, Hospital
2
2014
1815
0.060
Why?
Health Care Coalitions
1
2004
8
0.060
Why?
Genetic Engineering
1
2004
80
0.060
Why?
Cyproheptadine
4
1987
6
0.060
Why?
Patient Safety
2
2019
272
0.060
Why?
Odds Ratio
2
2020
953
0.060
Why?
Infant
2
2021
7922
0.050
Why?
Labor Unions
1
2003
3
0.050
Why?
United States Occupational Safety and Health Administration
1
2003
8
0.050
Why?
Planning Techniques
1
2003
12
0.050
Why?
Liability, Legal
4
1995
38
0.050
Why?
Japan
1
2002
85
0.050
Why?
Inservice Training
2
2016
106
0.050
Why?
Polyvinyls
1
2002
17
0.050
Why?
Chromatography, High Pressure Liquid
1
1984
463
0.050
Why?
Awareness
1
2003
93
0.050
Why?
Quality of Life
2
2023
2335
0.050
Why?
Hydroxyzine
1
2022
3
0.050
Why?
Antibodies, Monoclonal
1
1988
1236
0.050
Why?
Databases as Topic
1
2002
63
0.050
Why?
Administration, Cutaneous
1
2002
116
0.050
Why?
Polymethacrylic Acids
1
2002
61
0.050
Why?
Point-of-Care Systems
1
2023
130
0.050
Why?
Pharmacy Service, Hospital
2
1993
83
0.050
Why?
Aged, 80 and over
1
2012
6296
0.050
Why?
Hypoglycemic Agents
1
2009
1006
0.050
Why?
Heart Diseases
1
2005
327
0.050
Why?
Feedback
1
2002
141
0.050
Why?
Patents as Topic
1
2021
1
0.050
Why?
Varenicline
1
2021
22
0.050
Why?
Maryland
1
2000
37
0.050
Why?
Perception
1
2003
307
0.050
Why?
Conservation of Natural Resources
1
2002
86
0.050
Why?
Hand Hygiene
1
2020
7
0.050
Why?
Breast Neoplasms
1
2012
1842
0.040
Why?
Radiologists
1
2020
35
0.040
Why?
Journalism, Medical
1
2000
5
0.040
Why?
Labor, Obstetric
1
2000
51
0.040
Why?
Music
1
2000
35
0.040
Why?
Computer Graphics
1
2020
40
0.040
Why?
Freedom
1
2000
12
0.040
Why?
Masks
1
2020
46
0.040
Why?
Dentistry
1
2020
12
0.040
Why?
Death
1
2000
106
0.040
Why?
International Agencies
1
2020
29
0.040
Why?
Social Values
1
2000
36
0.040
Why?
Social Perception
1
2001
94
0.040
Why?
Cost of Illness
1
2022
255
0.040
Why?
Insulin
1
2009
2076
0.040
Why?
Public Health Surveillance
1
2020
61
0.040
Why?
Patient Compliance
1
2003
523
0.040
Why?
Ethics
2
1996
5
0.040
Why?
Electrocardiography
1
2022
558
0.040
Why?
Patient Care Team
1
2003
518
0.040
Why?
Employment
1
2020
137
0.040
Why?
Foundations
1
2018
22
0.040
Why?
Social Behavior
1
2001
266
0.040
Why?
Contracts
1
1998
9
0.040
Why?
Breast Feeding
1
2021
366
0.040
Why?
Fiji
1
2017
3
0.040
Why?
Consensus
1
2019
533
0.040
Why?
Health Status Indicators
1
1998
155
0.040
Why?
Forecasting
1
2018
329
0.030
Why?
Technology Assessment, Biomedical
1
1997
29
0.030
Why?
Child, Preschool
1
2010
9093
0.030
Why?
Sampling Studies
1
1996
90
0.030
Why?
Air Pollution
1
2018
166
0.030
Why?
Animals, Newborn
3
1987
769
0.030
Why?
Software
1
2020
525
0.030
Why?
Capacity Building
1
2016
51
0.030
Why?
Models, Statistical
1
2020
593
0.030
Why?
Diffusion of Innovation
1
1997
91
0.030
Why?
CD-ROM
1
1995
6
0.030
Why?
Medical Informatics Applications
1
1995
7
0.030
Why?
Diabetes Mellitus, Type 2
1
2009
2088
0.030
Why?
Anti-Infective Agents, Local
1
2016
39
0.030
Why?
Developed Countries
1
1995
25
0.030
Why?
Regional Medical Programs
1
1995
4
0.030
Why?
DNA-Binding Proteins
1
2022
1286
0.030
Why?
Analysis of Variance
1
1998
1208
0.030
Why?
Influenza, Human
1
2020
543
0.030
Why?
Communication Barriers
1
1996
88
0.030
Why?
Drugs, Investigational
1
2015
30
0.030
Why?
Palliative Care
1
2000
635
0.030
Why?
Poison Control Centers
1
1995
84
0.030
Why?
Education, Medical, Undergraduate
1
1995
158
0.030
Why?
Drug Contamination
1
2013
52
0.030
Why?
Drug Stability
1
2013
149
0.030
Why?
Solubility
1
2013
221
0.030
Why?
Family Practice
1
1996
426
0.030
Why?
Dementia
1
2015
186
0.020
Why?
Precision Medicine
1
2015
335
0.020
Why?
Hospital Bed Capacity, 300 to 499
1
1991
4
0.020
Why?
Referral and Consultation
2
1995
632
0.020
Why?
Confidence Intervals
1
2012
302
0.020
Why?
Dissent and Disputes
1
2011
17
0.020
Why?
National Health Programs
1
2010
20
0.020
Why?
Chronic Disease
1
2016
1570
0.020
Why?
Zambia
1
2010
46
0.020
Why?
Observer Variation
1
1991
298
0.020
Why?
Public Health Practice
1
2010
61
0.020
Why?
Training Support
1
2010
22
0.020
Why?
Geriatric Assessment
1
1991
175
0.020
Why?
Midwifery
1
2010
45
0.020
Why?
San Francisco
3
1995
54
0.020
Why?
Endpoint Determination
1
2009
68
0.020
Why?
beta-Endorphin
1
1988
7
0.020
Why?
Aging
3
1987
1601
0.020
Why?
Obstetrics
1
2010
146
0.020
Why?
Early Detection of Cancer
1
2012
305
0.020
Why?
Migraine Disorders
1
2009
82
0.020
Why?
Molecular Weight
1
1988
323
0.020
Why?
Immunoglobulin Fab Fragments
1
1988
69
0.020
Why?
Iodine Radioisotopes
1
1988
126
0.020
Why?
Enkephalin, D-Penicillamine (2,5)-
1
1987
1
0.020
Why?
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
1
1987
3
0.020
Why?
Endorphins
1
1987
7
0.020
Why?
Receptors, Opioid, kappa
1
1987
10
0.020
Why?
Enkephalins
1
1987
13
0.020
Why?
Dynorphins
1
1987
8
0.020
Why?
Hydrazines
1
1987
27
0.020
Why?
Receptors, Opioid, mu
1
1987
50
0.020
Why?
Pyrrolidines
1
1987
55
0.020
Why?
Bipolar Disorder
1
2009
200
0.020
Why?
p-Chloroamphetamine
1
1987
1
0.020
Why?
5,7-Dihydroxytryptamine
1
1987
3
0.020
Why?
Hydroxyindoleacetic Acid
1
1987
19
0.020
Why?
Reserpine
1
1986
5
0.020
Why?
Sympatholytics
1
1986
12
0.020
Why?
Corticosterone
1
1987
202
0.020
Why?
Haloperidol
1
1986
35
0.020
Why?
Hypothalamo-Hypophyseal System
1
1987
160
0.020
Why?
Norepinephrine
1
1986
197
0.020
Why?
Piperazines
1
1987
309
0.010
Why?
Electrochemistry
1
1984
77
0.010
Why?
Clinical Competence
1
2010
882
0.010
Why?
Peptide Fragments
1
1987
652
0.010
Why?
Dopamine
1
1986
234
0.010
Why?
Fetus
1
1987
697
0.010
Why?
Reading
1
2002
135
0.010
Why?
Alendronate
1
2000
8
0.010
Why?
Pravastatin
1
2000
27
0.010
Why?
Television
1
2000
72
0.010
Why?
Outpatients
2
1993
324
0.010
Why?
Anticholesteremic Agents
1
2000
129
0.010
Why?
Aspirin
1
2000
325
0.010
Why?
European Union
1
1997
8
0.010
Why?
Clinical Trials, Phase IV as Topic
1
1995
2
0.010
Why?
Fees, Medical
1
1995
9
0.010
Why?
Hotlines
1
1995
29
0.010
Why?
Physicians' Offices
1
1995
16
0.010
Why?
Home Nursing
1
1995
26
0.010
Why?
Hospital Charges
1
1995
39
0.010
Why?
Propofol
1
1995
43
0.010
Why?
Poisoning
1
1995
110
0.010
Why?
Insurance, Health
1
1995
243
0.010
Why?
Medication Errors
1
1993
88
0.010
Why?
Frail Elderly
1
1993
106
0.010
Why?
Hospitals, Community
1
1992
45
0.010
Why?
Medical Staff, Hospital
1
1992
74
0.010
Why?
Curriculum
1
1995
803
0.010
Why?
Endocrine Glands
1
1987
15
0.000
Why?
Alcoholic Beverages
1
1987
17
0.000
Why?
Narcotics
1
1987
44
0.000
Why?
Follow-Up Studies
1
1995
4384
0.000
Why?
Maternal-Fetal Exchange
1
1987
151
0.000
Why?
Cocaine
1
1987
153
0.000
Why?
Marijuana Abuse
1
1987
207
0.000
Why?
Child Development
1
1987
381
0.000
Why?
Disease Models, Animal
1
1987
3470
0.000
Why?
Bero's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)